Steris PLC (STE)
228.30
+1.49
(+0.66%)
USD |
NYSE |
May 24, 15:39
Steris Cash from Investing (Quarterly): -95.61M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -95.61M |
December 31, 2023 | -118.92M |
September 30, 2023 | -606.24M |
June 30, 2023 | -66.60M |
March 31, 2023 | -77.58M |
December 31, 2022 | -98.41M |
September 30, 2022 | -97.92M |
June 30, 2022 | -109.42M |
March 31, 2022 | 93.58M |
December 31, 2021 | -79.80M |
September 30, 2021 | -76.80M |
June 30, 2021 | -603.53M |
March 31, 2021 | -118.26M |
December 31, 2020 | -923.04M |
September 30, 2020 | -46.14M |
June 30, 2020 | -66.72M |
March 31, 2020 | -59.75M |
December 31, 2019 | -74.53M |
September 30, 2019 | -101.15M |
June 30, 2019 | -84.31M |
March 31, 2019 | -73.66M |
December 31, 2018 | -71.41M |
September 30, 2018 | -33.29M |
June 30, 2018 | -34.87M |
March 31, 2018 | -55.00M |
Date | Value |
---|---|
December 31, 2017 | -47.29M |
September 30, 2017 | -46.66M |
June 30, 2017 | -54.88M |
March 31, 2017 | -61.39M |
December 31, 2016 | -34.12M |
September 30, 2016 | 26.90M |
June 30, 2016 | -35.64M |
March 31, 2016 | -43.18M |
December 31, 2015 | -425.67M |
September 30, 2015 | -192.93M |
June 30, 2015 | -67.80M |
March 31, 2015 | -40.45M |
December 31, 2014 | -28.21M |
September 30, 2014 | -12.84M |
June 30, 2014 | -202.27M |
March 31, 2014 | -80.17M |
December 31, 2013 | -21.26M |
September 30, 2013 | -25.37M |
June 30, 2013 | -21.85M |
March 31, 2013 | -23.79M |
December 31, 2012 | -141.63M |
September 30, 2012 | -306.11M |
June 30, 2012 | -15.52M |
March 31, 2012 | -24.77M |
December 31, 2011 | -19.79M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-923.04M
Minimum
Dec 2020
93.58M
Maximum
Mar 2022
-170.56M
Average
-89.96M
Median
Cash from Investing (Quarterly) Benchmarks
Edwards Lifesciences Corp | 63.10M |
ResMed Inc | -33.15M |
Align Technology Inc | -79.58M |
ThermoGenesis Holdings Inc | -0.02M |
Nutriband Inc | -0.0491M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 254.81M |
Cash from Financing (Quarterly) | -143.77M |
Free Cash Flow | 612.95M |
Free Cash Flow Per Share (Quarterly) | 1.642 |
Free Cash Flow to Equity (Quarterly) | 352.66M |
Free Cash Flow to Firm (Quarterly) | 163.31M |
Free Cash Flow Yield | 2.70% |